Name: UMIN ID:
Unique ID issued by UMIN | UMIN000004197 |
---|---|
Receipt number | R000005044 |
Scientific Title | Phase II Study of FOLFOX + Erbitux as first Line therapy in metastatic colorectal cancer with EGFR-detectable and KRAS wild type |
Date of disclosure of the study information | 2010/09/13 |
Last modified on | 2016/11/24 13:12:21 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/09/13 14:01:45 | ||
2 | Update | 2016/11/24 13:08:33 | Key inclusion criteria |
|
3 | Update | 2016/11/24 13:09:33 | Email Name of primary person or sponsor Organization Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
4 | Update | 2016/11/24 13:12:21 | Recruitment status Publication of results URL related to results and publications |